(Total Views: 889)
Posted On: 07/30/2020 5:48:19 PM
Post# of 153864
I sent an email as well, suggesting language for the next PR to avoid additional short attacks:
Dr. Pourshassan,
Congratulations on the excellent results. Thank you for being such an able steward of Cytodyn and Leronlimab.
As you pointed out, you and Cytodyn have been subject to repeatedly baseless criticism, most recently for releasing outstanding CD10 safety data in advance of efficacy results.
I suggest, if feasible, that the excellent Day 3 topline and N.E.W.S results from days 3,7, and 14 be presented as "Positive results have been seen in all endpoints for which data analysis is complete. Data from the remaining endpoints will be released as soon as analysis is completed."
This leaves little room for further unjust criticism as results are compiled and released.
Thank you for all you do.
Respectfully,
S
Dr. Pourshassan,
Congratulations on the excellent results. Thank you for being such an able steward of Cytodyn and Leronlimab.
As you pointed out, you and Cytodyn have been subject to repeatedly baseless criticism, most recently for releasing outstanding CD10 safety data in advance of efficacy results.
I suggest, if feasible, that the excellent Day 3 topline and N.E.W.S results from days 3,7, and 14 be presented as "Positive results have been seen in all endpoints for which data analysis is complete. Data from the remaining endpoints will be released as soon as analysis is completed."
This leaves little room for further unjust criticism as results are compiled and released.
Thank you for all you do.
Respectfully,
S
(9)
(0)
